期刊文献+

白细胞介素28B基因多态性与丙型肝炎病毒的清除

Polymorphisms of the gene interleukin-28B and the hepatitis C virus clearance
原文传递
导出
摘要 宿主因素在HCV自发清除或治疗诱导清除的过程中都发挥着重要作用。有证据表明,编码IFNλ3的IL-28B基因多态性和HCV的清除有关,IL-28B基因亚型和其他因素皆可预测聚乙二醇IFNa联合利巴韦林的抗病毒疗效。此文针对IL-28B基因多态性与HCV的清除、IFN入生物学特性及其临床意义作了综述。 Treatment-induced control and spontaneous clearance of HCV are affected by various of host factors. The polymorphisms of the gene IL-28B which is implicating the gene product IFN λ3 are associated with HCV clearance. The IL-28B genotype can be considered, along with other factors, in predicting patient responses to therapy with Peg-IFN a and ribavirin. The genetic studies that uncovered the association between IL-28B and HCV clearance, the biology of IFN λ3, the clinical implications of the genetic association are reviewed.
出处 《国际流行病学传染病学杂志》 CAS 2011年第4期271-274,共4页 International Journal of Epidemiology and Infectious Disease
关键词 肝炎病毒 丙型 IL-28B 干扰素λ Hepatitis C virus IL-28B Interferon λ
  • 相关文献

参考文献22

  • 1Thomas DL, Thio CL, Martin MP, et al. Genetic variation in IL-28B and spontoneous clearance of hepatitis C virus. Nature, 2009, 461 (7265) : 798-801.
  • 2C,e D, Fellay J, Thompson AJ, et al. Genetic variation in IL-28B predicts hepatitis C treatment-induced viral clearance. Nature,2009, 461(7265): 399-401.
  • 3Rauch A, Kutalik Z, Descombes P, et al. Genetic variation in ID28B is associated with chronic hepatitis C and treatment failure: a genome-wide association stttdy. Gastroenterology, 2010, 138 ( 4 ): 1338-1345, 1345. e1-7.
  • 4Montes-C, ano MA, Garcia-Lozano JR, Abad-Molina C, et al. Interleukln-28B genetic variants and hepatitis rims infection by different rind genotypes. Hepatology,2010,52(1) : 33-37.
  • 5Tillmarm HL, Thompson AJ, Patel K, et al. A polynmrphism near IL-28B is associated with spontaneous clearance d acute hepatitis C virus and jaundice. Gastroenterology,2010,139(5) : 1586-1592.
  • 6Mangia A, Thompson AJ, Santoro R, et al. An IL-28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response. Gastroenterology,2010,139(3) : 821-827.
  • 7McCarthy JJ, Li JH, Thompson A, et al. Replicated association between an IL-28B gene variant and a sustained response to pegylated interferon and ribavirin. Gastroenterology, 2010, 138 (7): 2307- 2314.
  • 8Rallon NI, Naggie S, Benito JM, et al. Association of a single nueleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients. AIDS,2010, 24(8) : F23-F29.
  • 9Honda M, Sakai A, Yamashita T, et al. Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of interfewn therapy for chronic hepatitis C. Gastroenterology,2010,139 (2) : 499-509.
  • 10Sarasin-Filipowicz M, Oakeley EJ, Duong FH, et al. Interferon signaling and treatment outcome in chronic hepatitis C. Proc Nail Acad Sci USA, 2008,105(19): 7034-7039.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部